|
| 36258154 | Comparing IUC and Tubal Ligation. | J Gen Intern Med | 2023 |
| 37562637 | Contraceptive efficacy should primarily be measured using life table pregnancy rates. | Contraception | 2023 |
| 37524147 | Early pregnancy loss medical management in clinical practice. | Contraception | 2023 |
| 37854030 | The benefits of estetrol addition to drospirenone for contraception. | AJOG Glob Rep | 2023 |
| 37544572 | The efficacy, safety, and tolerability of an estrogen-free oral contraceptive drospirenone 4Â mg (24/4-day regimen) in obese users. | Contraception | 2023 |
| 37495438 | Corrigendum to 'Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use' [American Journal of Obstetrics and Gynecology 2022;227:871.e1-871.e7]. | Am J Obstet Gynecol | 2023 |
| 37023457 | Combined Oral Contraceptive Adherence and Pregnancy Rates. | Obstet Gynecol | 2023 |
| 37023455 | Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device. | Obstet Gynecol | 2023 |
| 37023451 | Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use. | Obstet Gynecol | 2023 |
| 37255853 | Hormonal therapies and venous thrombosis: considerations for prevention and management-a reappraisal. | Res Pract Thromb Haemost | 2023 |
| 36970737 | Hormonal therapies and venous thrombosis: Estrogen matters! | Res Pract Thromb Haemost | 2023 |
| 36918065 | Complex Family Planning fellowship graduates' intended practice plans and barriers to practicing in areas of unmet need. | Contraception | 2023 |
| 36849033 | Medication abortion with misoprostol-only: A sample protocol. | Contraception | 2023 |
| 36473510 | Clinical interventions are more accurate than quantitative measurements for defining hemorrhage with dilation and evacuation. | Contraception | 2023 |
| 36735418 | Texas Senate Bill 8 and Abortion Experiences in Patients With Fetal Diagnoses: A Qualitative Analysis. | Obstet Gynecol | 2023 |
| 36940910 | Management of cesarean scar ectopic pregnancies at an academic referral center: A case series. | Contraception | 2023 |
| 36130667 | The effect of deliberate non-adherence to a norgestrel progestin-only pill: A randomized, crossover study. | Contraception | 2023 |
| 34245666 | Estetrol-Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia. | BJOG | 2022 |
| 35351445 | Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity. | Contraception | 2022 |
| 35640733 | Recommendations for standardization of bleeding data analyses in contraceptive studies. | Contraception | 2022 |
| 35367204 | Mechanism of action of a 0.075 mg norgestrel progestogen-only pill 2. Effect on cervical mucus and theoretical risk of conception. | Contraception | 2022 |
| 35569516 | Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use. | Am J Obstet Gynecol | 2022 |
| 35750146 | Implementation of telemedicine preoperative visits for abortion procedures through 18 weeks gestation at a Northern California hospital-based center. | Contraception | 2022 |
| 36441935 | ACOG Clinical Consensus No. 3: General Approaches to Medical Management of Menstrual Suppression. | Obstet Gynecol | 2022 |
| 35865736 | Continuation rates of two different-sized copper intrauterine devices among nulliparous women: Interim 12-month results of a single-blind, randomised, multicentre trial. | EClinicalMedicine | 2022 |
| 36201766 | Long-Acting Reversible Contraception. | Obstet Gynecol | 2022 |
| 35921872 | Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women. | Contraception | 2022 |
| 35921870 | Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials. | Contraception | 2022 |
| 36257374 | Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials. | Contraception | 2022 |
| 35306927 | Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause. | Expert Rev Clin Pharmacol | 2022 |
| 34464634 | Mifepristone prior to osmotic dilators for dilation and evacuation cervical preparation: A randomized, double-blind, placebo-controlled pilot study. | Contraception | 2022 |
| 34748751 | Contraceptive plans before preoperative assessment and at procedure in surgical abortion patients. | Contraception | 2022 |
| 34748746 | Society of Family Planning Committee statement on IUD nomenclature. | Contraception | 2022 |
| 33038303 | Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta®) discontinuation. | Contraception | 2021 |
| 33744301 | Ethinyl estradiol and levonorgestrel patch phase 3 data clarification. | Contraception | 2021 |
| 33571492 | US referral center experience removing nonpalpable and difficult contraceptive implants with in-office ultrasonography: A case series. | Contraception | 2021 |
| 33713682 | Coronavirus disease 2019 impact on abortion care at a Northern California tertiary family planning program. | Am J Obstet Gynecol | 2021 |
| 33651995 | Relationship of parity and prior cesarean delivery to levonorgestrel 52 mg intrauterine system expulsion over 6 years. | Contraception | 2021 |
| 33706339 | Medication Abortion With Pharmacist Dispensing of Mifepristone. | Obstet Gynecol | 2021 |
| 34623082 | Pain Associated With Cervical Priming for First-Trimester Surgical Abortion: A Randomized Controlled Trial. | Obstet Gynecol | 2021 |
| 34273335 | Standardizing abortion research outcomes (STAR): Results from an international consensus development study. | Contraception | 2021 |
| 34000251 | Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results. | Contraception | 2021 |
| 34281806 | Pharmacists' knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion. | J Am Pharm Assoc (2003) | 2021 |
| 33970869 | Assessing the Pregnancy Protective Impact of Scheduled Nonadherence to a Novel Progestin-Only Pill: Protocol for a Prospective, Multicenter, Randomized, Crossover Study. | JMIR Res Protoc | 2021 |
| 33098853 | Twelve-month prescribing of contraceptive pill, patch, and ring before and after a standardized electronic medical record order change. | Contraception | 2021 |
| 31226319 | Comparing preoperative dating and postoperative dating for second-trimester surgical abortions. | Contraception | 2020 |
| 32059839 | Family planning, population growth, and the environment. | Contraception | 2020 |
| 31786203 | Six-year contraceptive efficacy and continued safety of a levonorgestrel 52⿯mg intrauterine system. | Contraception | 2020 |
| 31809439 | Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial. | Obstet Gynecol | 2020 |
| 31866516 | Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding. | Am J Obstet Gynecol | 2020 |